Although we have only investigated three major PD-related phenotypes, as LRRK2 is involved in multiple pathways, our model could be used to interrogate other phenotypes that have been reported in patient-derived cells; for example, abnormal nuclear envelope architecture, altered neurite length and branching, and increased mitochondrial DNA damage. The gene discussed is LRRK2; the disease is Parkinson disease.